New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Vera Therapeutics, Inc.
VERA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Biotechnology

Next Earning date - 19 Mar 2025

2B

Biotechnology

Next Earning date - 19 Mar 2025

27.46USD

Shape-6.72 ( -19.66%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

793%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

47%

Quote Panel

Shape
Updated February 17, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

VERA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

ShapeNaN%

2025-Revenue

$3.16

Shape-272%

2025-EPS

$1M

Shape103%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Wolfe Research

initialise

Previous: Not converted

2025-02-04

Now: Outperform

Oppenheimer

initialise

Previous: Not converted

2024-01-26

Now: Outperform

Raymond James

upgrade

Previous: Not converted

2024-01-26

Now: Strong Buy

Jefferies

upgrade

Previous: Not converted

2023-11-10

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-1.19
vs -0.79

Q1.23

arrow
arrow

N/A

-0.80
vs -0.71

Q2.23

arrow
arrow

N/A

-0.46
vs -0.55

Q3.23

arrow
arrow

N/A

-0.45
vs -0.91

Q4.23

arrow
arrow

N/A

-0.58
vs -1.19

Q1.24

arrow
arrow

N/A

-0.56
vs -0.80

Q2.24

arrow
arrow

N/A

-0.62
vs -0.46

Q3.24

arrow
arrow

N/A

-0.85
vs -0.45

Q4.24

arrow
arrow

N/A

-0.81
vs -0.58

Q1.25

arrow
arrow

N/A

-0.85
vs -0.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-42%

-0.42
vs -0.23

Q1.23

arrow
arrow

-19%

-0.19
vs -0.42

Q2.23

arrow
arrow

-14%

-0.14
vs -0.19

Q3.23

arrow
arrow

-16%

-0.16
vs -0.14

Q4.23

arrow
arrow

-25%

-0.25
vs -0.16

Q1.24

arrow
arrow

-8%

-0.08
vs -0.25

Q2.24

arrow
arrow

-10%

-0.10
vs -0.08

Q3.24

arrow
arrow

-16%

-0.16
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

73

73
vs 58

26%

Q2.23

arrow
arrow

84

84
vs 73

15%

Q3.23

arrow
arrow

86

86
vs 84

2%

Q4.23

arrow
arrow

97

97
vs 86

13%

Q1.24

arrow
arrow

170

170
vs 97

75%

Q2.24

arrow
arrow

175

175
vs 170

3%

Q3.24

arrow
arrow

178

178
vs 175

2%

Q4.24

arrow
arrow

174

174
vs 178

-2%

Earnings Growth

Latest News